ascopubs.org

Impact of extent of surgical resection on survival outcomes in patients with IDH-mutant anaplastic astrocytomas and IDH mutant anaplastic oligodendrogliomas: A SEER database study.

Detection of methylated MGMT using radiomic imaging: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...
Nasdaq

Mustang Bio Announces FDA Orphan Drug Designation for MB-101 in Treatment of Recurrent Glioblastoma and High-Grade Astrocytomas

Mustang Bio, Inc. announced that its IL13Ra2-targeted CAR T-cell therapy, MB-101, received Orphan Drug Designation from the FDA for treating recurrent diffuse and anaplastic astrocytomas and ...
Cure Today

FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas

MB-101 received orphan drug designation for treating recurrent diffuse astrocytomas and glioblastoma, supporting rare disease treatments affecting fewer than 200,000 people in the U.S. Combining ...